Eaton Vance Management Artivion, Inc. Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$16.95 - $21.74 $32,510 - $41,697	-1,918 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.19 - $22.84 $19,854 - $26,380	1,155 Added 151.38%	1,918 $0
Q3 2021 Nov 15, 2021	SELL	$22.29 - $28.7 $1,292 - $1,664	-58 Reduced 7.06%	763 $0
Q2 2021 Aug 16, 2021	BUY	$22.32 - $32.07 $11,115 - $15,970	498 Added 154.18%	821 $23,000
Q1 2021 May 17, 2021	BUY	$22.07 - $26.31 $7,128 - $8,498	323 New	323 $7,000

174

35.8M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.15B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.